IP Library Granted Patent US 7,972,778
Granted Patent B2
US 7,972,778 · App. 10/798,857 · Granted Jul 5, 2011

Method for detecting the presence of a single target nucleic acid in a sample

Assignees: Applied Biosystems, LLC; The United States of America as represented by the Department of Health and Human Services
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,972,778
App. No.
10/798,857
Granted
Jul 5, 2011
Kind
B2
Abstract

A miniaturized assembly is provided whereby a fluid sample can be divided into a plurality of sample portions in retaining wells and the sample fluid can be displaced from open ends of the wells while simultaneously being sealed in the wells. A method of dividing a fluid sample using the assembly is also provided.

Claims (52)

1. A method for detecting a target nucleic acid molecule in a sample, said method comprising:

providing a sample containing at least one molecule of a target nucleic acid and constituents for enabling amplification of the target nucleic acid molecule;

loading the sample into a sample chamber comprising a flow through channel, said sample chamber including a device for retaining a reaction product of amplification of the target nucleic acid;

subjecting the sample in said sample chamber to a homogeneous amplification assay comprising at least a first round of amplification under conditions such that amplification of said target nucleic acid occurs and a reaction product of the amplification of a single molecule of the target nucleic acid comprises a clonal amplified product having a detectable concentration within a portion of said sample chamber after a single round of amplification; and

detecting the clonal amplified product of said target nucleic acid after said first round of amplification.

2. A method as recited in claim 1 , wherein said sample has a volume of about 1 picoliter or less.

3. A method as recited in claim 1 , wherein said sample has a volume of about 1 nanoliter or less.

4. A method as recited in claim 1 , wherein said sample has a volume of about 10 nanoliters or less.

5. A method as recited in claim 1 , wherein said sample has a volume of about 100 nanoliters or less.

6. A method as recited in claim 1 , wherein said sample has a volume of about 1 microliter or less.

7. A method as recited in claim 1 , wherein said sample has a volume which is nanoliter-sized.

8. A method for detecting a target nucleic acid molecule in a sample, said method comprising:

providing a sample containing at least one molecule of a target nucleic acid and constituents for enabling amplification of the target nucleic acid molecule;

loading the sample into a sample chamber comprising a flow through channel, said sample chamber including means for retaining a reaction product of amplification of the target nucleic acid;

subjecting the sample to a homogeneous amplification assay comprising at least a first round of amplification under conditions such that amplification of said target nucleic acid occurs and a reaction product of the amplification of a single molecule of the target nucleic acid comprises a clonal amplified product having a detectable concentration within a portion of said sample chamber after a single round of amplification; and

detecting the clonal amplified product of said target nucleic acid after said first round of amplification.

9. A method as recited in claim 8 , wherein said sample has a volume of about 1 picoliter or less.

10. A method as recited in claim 8 , wherein said sample has a volume of about 1 nanoliter or less.

11. A method as recited in claim 8 , wherein said sample has a volume of about 10 nanoliters or less.

12. A method as recited in claim 8 , wherein said sample has a volume of about 100 nanoliters or less.

13. A method as recited in claim 8 , wherein said sample has a volume of about 1 microliter or less.

14. A method as recited in claim 8 , wherein said sample chamber is confined in at least one dimension by opposing barriers separated by a dimension of about 100 microns or less.

15. A method as recited in claim 8 , wherein said sample chamber is confined in at least one dimension by opposing barriers separated by a dimension of about 500 microns or less.

16. A method as recited in claim 8 , wherein said sample chamber is positioned in a device which comprises a plurality of sample chambers.

17. A method for detecting a target nucleic acid molecule in a sample, said method comprising:

loading a sample into a sample chamber comprising a flow through channel, said sample chamber comprising constituents for enabling amplification of a target nucleic acid, said sample chamber including a device for retaining a reaction product of amplification of the target nucleic acid;

subjecting the sample in said sample chamber to a homogeneous amplification assay comprising at least a first round of amplification under conditions such that amplification of said target nucleic acid occurs and a reaction product of the amplification of a single molecule of the target nucleic acid comprises a clonal amplified product having a detectable concentration within a portion of said sample chamber after a single round of amplification; and

detecting the clonal amplified product of said target nucleic acid after said first round of amplification.

18. A method as recited in claim 17 , wherein said sample has a volume of about 1 picoliter or less.

19. A method as recited in claim 17 , wherein said sample has a volume of about 1 nanoliter or less.

20. A method as recited in claim 17 , wherein said sample has a volume of about 10 nanoliters or less.

21. A method as recited in claim 17 , wherein said sample has a volume of about 100 nanoliters or less.

22. A method as recited in claim 17 , wherein said sample has a volume of about 1 microliter or less.

23. A method as recited in claim 17 , wherein said sample chamber is confined in at least one dimension by opposing barriers separated by a dimension of about 100 microns or less.

24. A method as recited in claim 17 , wherein said sample chamber is confined in at least one dimension by opposing barriers separated by a dimension of about 500 microns or less.

25. A method as recited in claim 17 , wherein said sample chamber is positioned in a device which comprises a plurality of sample chambers.

26. A method for detecting a target nucleic acid molecule in a sample, said method comprising:

loading a sample into a sample chamber comprising a flow through channel, said sample chamber comprising constituents for enabling amplification of a target nucleic acid, said sample chamber including means for retaining a reaction product of amplification of the target nucleic acid;

subjecting the sample to a homogeneous amplification assay comprising at least a first round of amplification under conditions such that amplification of said target nucleic acid occurs and a reaction product of the amplification of a single molecule of the target nucleic acid comprises a clonal amplified product having a detectable concentration within a portion of said sample chamber after a single round of amplification; and

detecting the clonal amplified product of said target nucleic acid after said first round of amplification.

27. A method as recited in claim 26 , wherein said sample has a volume of about 1 picoliter or less.

28. A method as recited in claim 26 , wherein said sample has a volume of about 1 nanoliter or less.

29. A method as recited in claim 26 , wherein said sample has a volume of about 10 nanoliters or less.

30. A method as recited in claim 26 , wherein said sample has a volume of about 100 nanoliters or less.

31. A method as recited in claim 26 , wherein said sample has a volume of about 1 microliter or less.

32. A method as recited in claim 26 , wherein said sample chamber is confined in at least one dimension by opposing barriers separated by a dimension of about 100 microns or less.

33. A method as recited in claim 26 , wherein said sample chamber is confined in at least one dimension by opposing barriers separated by a dimension of about 500 microns or less.

34. A method as recited in claim 26 , wherein said sample chamber is positioned in a device which comprises a plurality of sample chambers.

35. A method for detecting a target nucleic acid molecule in a sample, said method comprising:

loading a sample into a sample chamber comprising a flow through channel, said sample chamber further comprising constituents for cloning a segment of DNA, said sample chamber including a device for retaining a reaction product from cloning the segment of DNA;

subjecting the sample in said sample chamber to a homogeneous amplification assay comprising at least a first round of amplification under conditions such that amplification of said segment of DNA occurs and a reaction product of the amplification of a single molecule of the target nucleic acid comprises the cloned DNA segment product having a detectable concentration within a portion of said sample chamber after a single round of amplification; and

detecting the cloned DNA segment after said first round of amplification.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 24, 2010
From: SILVER, JONATHAN E.
To: UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 025040/0092 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PROPERTY NOS.; CONVEYING PARTY INTEREST; CONVEYING PARTY NAME/ADDRESS PER MERGER RECORDED 6/9/2010, REEL 024508, FRAME 0142. PREVIOUSLY RECORDED ON REEL 023950 FRAME 0123. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 22, 2010
From: GENOMIC NANOSYSTEMS CORPORATION
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 024563/0930 →
MERGER Recorded Jun 9, 2010
From: GENOMIC NANOSYSTEMS, LLC
To: GENOMIC NANOSYSTEMS CORPORATION
Reel/Frame 024508/0142 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2010
From: GENOMIC NANOSYSTEMS, LLC
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 023950/0123 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2009
From: CYTONIX CORPORATION
To: GENOMIC NANOSYSTEMS, LLC
Reel/Frame 022427/0504 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 19, 2007
From: BROWN, JAMES F.
To: CYTONIX CORPORATION
Reel/Frame 019573/0881 →
Continuity (4)
Division 10131854 · Apr 25, 2002
Division 09563714 · May 2, 2000
Division 08838262 · Apr 17, 1997
Related Publication 20040171055A1 · Sep 2, 2004